- $30 BnWorld market, 2023
- $52.7 BnProjected, 2033
- 5.8%Growth a year (CAGR)
- 1,142Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$12.6 Bn
3.8% a year · 42% of the world -
2
China
$2.4 Bn
7.3% a year · 8% of the world -
3
Canada
$2.4 Bn
5.8% a year · 8% of the world -
4
Japan
$1.9 Bn
6.3% a year · 6.2% of the world -
5
Germany
$1.1 Bn
4% a year · 3.7% of the world -
6
France
$825 Mn
4.8% a year · 2.8% of the world -
7
UK
$780 Mn
3.8% a year · 2.6% of the world -
8
Brazil
$750 Mn
6.8% a year · 2.5% of the world -
9
Italy
$720 Mn
5.3% a year · 2.4% of the world -
10
Ecuador
$600 Mn
6.4% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)HIV Drugs by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $30 Bn | $52.7 Bn | 5.8% | – | 1,142 | Report on HIV Drugs in Global |
| North America | $15 Bn | $24 Bn | 4.8% | 50% | 526 | Report on HIV Drugs in North America |
| APAC | $6.3 Bn | $12.5 Bn | 7.1% | 21% | 102 | Report on HIV Drugs in APAC |
| Europe | $5.7 Bn | $8.9 Bn | 4.5% | 19% | 104 | Report on HIV Drugs in Europe |
| Latin America | $1.4 Bn | $2.6 Bn | 6.8% | 4.5% | 48 | Report on HIV Drugs in Latin America |
| Middle East | $1.2 Bn | $2.3 Bn | 6.8% | 4% | 0 | Report on HIV Drugs in Middle East |
| Africa | $450 Mn | $910 Mn | 7.3% | 1.5% | 142 | Report on HIV Drugs in Africa |
| US |
$12.6 Bn | $18.3 Bn | 3.8% | 42% | 506 | Report on HIV Drugs in US |
| China |
$2.4 Bn | $4.9 Bn | 7.3% | 8% | 30 | Report on HIV Drugs in China |
| Canada |
$2.4 Bn | $4.2 Bn | 5.8% | 8% | 33 | Report on HIV Drugs in Canada |
| Japan |
$1.9 Bn | $3.4 Bn | 6.3% | 6.2% | 9 | Report on HIV Drugs in Japan |
| Germany |
$1.1 Bn | $1.6 Bn | 4% | 3.7% | 15 | Report on HIV Drugs in Germany |
| France |
$825 Mn | $1.3 Bn | 4.8% | 2.8% | 59 | Report on HIV Drugs in France |
| UK |
$780 Mn | $1.1 Bn | 3.8% | 2.6% | 25 | Report on HIV Drugs in UK |
| Brazil |
$750 Mn | $1.4 Bn | 6.8% | 2.5% | 33 | Report on HIV Drugs in Brazil |
| Italy |
$720 Mn | $1.2 Bn | 5.3% | 2.4% | 24 | Report on HIV Drugs in Italy |
| Ecuador |
$600 Mn | $1.1 Bn | 6.4% | 2% | 0 | Report on HIV Drugs in Ecuador |
 Spain |
$579 Mn | $925 Mn | 4.8% | 1.9% | 25 | Report on HIV Drugs in Spain |
 India |
$546 Mn | $1.3 Bn | 8.8% | 1.8% | 8 | Report on HIV Drugs in India |
 Saudi Arabia |
$510 Mn | $1 Bn | 7.3% | 1.7% | 0 | Report on HIV Drugs in Saudi Arabia |
 Mexico |
$450 Mn | $810 Mn | 6.1% | 1.5% | 21 | Report on HIV Drugs in Mexico |
 Australia |
$360 Mn | $728 Mn | 7.3% | 1.2% | 21 | Report on HIV Drugs in Australia |
 South Africa |
$195 Mn | $385 Mn | 7% | 0.7% | 102 | Report on HIV Drugs in South Africa |
 UAE |
$150 Mn | $290 Mn | 6.8% | 0.5% | 0 | Report on HIV Drugs in UAE |
 Egypt |
$84 Mn | $170 Mn | 7.3% | 0.3% | 2 | Report on HIV Drugs in Egypt |
 Philippines |
$66 Mn | $122 Mn | 6.3% | 0.2% | 3 | Report on HIV Drugs in Philippines |
 Malaysia |
$48 Mn | $86 Mn | 6% | 0.2% | 8 | Report on HIV Drugs in Malaysia |
 Hong Kong |
$48 Mn | $93 Mn | 6.8% | 0.2% | 8 | Report on HIV Drugs in Hong Kong |
 Singapore |
$36 Mn | $67 Mn | 6.4% | 0.1% | 1 | Report on HIV Drugs in Singapore |
 Thailand |
$36 Mn | $65 Mn | 6.1% | 0.1% | 35 | Report on HIV Drugs in Thailand |
 Kenya |
$21 Mn | $41 Mn | 6.9% | 0.1% | 45 | Report on HIV Drugs in Kenya |
 New Zealand |
– | – | – | – | 1 | Report on HIV Drugs in New Zealand |
 Russia |
– | – | – | – | 7 | Report on HIV Drugs in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 40,122 papers since 2021
- Mpox hospitalizations and HIV-associated immunosuppression at a single center in China: clinical characteristics, treatment, and outcomes. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2026
- Modelling minimum resource requirements to reach Ending the HIV Epidemic (EHE) goal in KwaZulu-Natal, South Africa. Journal of acquired immune deficiency syndromes (1999), 2026
- Transition From Oral to Long-Acting Injectable Preexposure Prophylaxis: Comparative Levels of Cabotegravir, Tenofovir, and Emtricitabine in Plasma and Seminal Fluids. Therapeutic drug monitoring, 2026
- Seeking Help Without Being Seen: A Qualitative Study of Online Health Information Seeking Among People Living with HIV/AIDS (PLWHA) in a Stigmatized Care Context. AIDS and behavior, 2026
- Longitudinal changes in cardiac structure and function among young adults with perinatal HIV infection or HIV exposure. AIDS (London, England), 2026
Patients: New HIV infections
| Place | Value | Year |
|---|---|---|
| World | 1,200,000 | 2025 |
| Australia | 500 | 2025 |
| Brazil | 69,000 | 2025 |
| Canada | 1,900 | 2022 |
| Ecuador | 2,000 | 2025 |
| Egypt | 6,300 | 2025 |
| France | 3,400 | 2024 |
| Germany | 2,300 | 2024 |
| India | 60,000 | 2025 |
| Italy | 3,700 | 2025 |
| Kenya | 14,000 | 2025 |
| Malaysia | 2,900 | 2025 |
| Mexico | 22,000 | 2025 |
| New Zealand | 100 | 2025 |
| Philippines | 34,000 | 2025 |
| Saudi Arabia | 1,300 | 2025 |
| Singapore | 200 | 2025 |
| South Africa | 130,000 | 2025 |
| Spain | 3,100 | 2025 |
| Thailand | 7,300 | 2025 |
| UAE | 200 | 2025 |
| UK | 2,100 | 2024 |
Compare HIV Drugs side by side
Key companies in HIV Drugs
Gilead Sciences Inc.
ViiV Healthcare
Merck & Co., Inc.
GlaxoSmithKline plc
Bristol Myers Squibb
Johnson & Johnson
AbbVie Inc.
F. Hoffmann-La Roche Ltd
Quick answers
How big is the HIV Drugs market?
The world HIV Drugs market was worth about $30 Bn in 2023 and is projected to reach $52.7 Bn by 2033, growing 5.8% a year (CAGR).
Which country has the largest HIV Drugs market?
The US is the largest of the 24 countries we cover, at $12.6 Bn in 2023. India grows fastest, at 8.8% a year.
How many clinical trials are running in HIV Drugs?
ClinicalTrials.gov lists 1,142 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on HIV Drugs?
PubMed lists about 40,122 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Patients: WHO Global Health Observatory. Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.